BAP1 is a tumor suppressor gene and individuals with cutaneous melanocytic neoplasm with a germline BAP1 mutation, often have BRAF mutations, with these lesions reported to have a benign clinical course [43]. Here, BAP1 is linked to melanocytic skin neoplasm.